Amphinex
Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.
It has had promising preliminary results in early trials on patients with advanced head and neck cancer[1] [2] [3]
References[edit | edit source]
- ↑ "Archived copy". Archived from the original on 2011-07-24. Retrieved 2010-04-06.
{{cite web}}
: Unknown parameter|deadurl=
ignored (help)CS1 maint: archived copy as title (link) Successful completion of the third dose group in the Amphinex study. March 2010 - ↑ http://www.medicalnewstoday.com/articles/176431.php PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial. Jan 2010
- ↑ "Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15
Amphinex Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD